The Saudi Food and Drug Authority (SFDA) has approved the registration of Pfizer-BioNTech COVID-19 Vaccine for import and use in the country, according to Saudi Press Agency.
This was after Pfizer submitted a request to approve registering the vaccine.
The decision of the Authority’s approval of registering the vaccine was based on the data provided by Pfizer on November 24. As soon as the requirements were completed, the Authority began reviewing and evaluating the registration files from several aspects.
Regarding the arrival date of the vaccine and the start of using it, the Authority said that based on the approval issued today, concerned health authorities will start the import procedures according to concerned standards and requirements. The Authority will analyze samples from each incoming vaccine shipment before using it to ensure its quality. The Ministry of Health will announce the date of the vaccine’s arrival and the start of using it after completing import requirements.
On Wednesday, Canada has announced its approval for using the Pfizer-BioNTech Covid-19 vaccine in the country, which is currently in the midst of a second wave of the pandemic.
Wednesday’s announcement came two days after Prime Minister Justin Trudeau notified that up to 249,000 doses of the two-dose vaccine will be on hand by this year’s end to start a mass inoculation campaign, reports Xinhua news agency.
The first doses of the Pfizer vaccine are expected to arrive in Canada next week, and plans are already in place to have the shots ready to be administered at 14 delivery sites in major cities across Canada, within one or two days of shipments arriving.
Also Read; Kushner set to mediate Saudi-Qatar Discussions
Also Read; US lauds UAE’s role in fostering religious cooperation